Found: 23
Select item for more details and to access through your institution.
Peripheral Blood B Lymphocytes in Multiple Myeloma.
- Published in:
- Acta Haematologica, 1994, v. 91, n. 2, p. 57, doi. 10.1159/000204253
- By:
- Publication type:
- Article
A phase 2 study of carfilzomib plus elotuzumab plus dexamethasone for myeloma patients relapsed after 1-3 prior treatment lines.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e279, doi. 10.1016/j.clml.2019.09.460
- By:
- Publication type:
- Article
Type I Diabetic Pregnancy and Subclinical Human Papillomavirus Infection.
- Published in:
- Clinical Infectious Diseases, 1997, v. 24, n. 2, p. 153
- By:
- Publication type:
- Article
Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 4, p. 561, doi. 10.1111/bjh.12139
- By:
- Publication type:
- Article
Depth of response assessed by quantitative ASO-PCR predicts the outcome after stem cell transplantation in multiple myeloma Putkonen et al. Post-transplant MRD in MM.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 5, p. 416, doi. 10.1111/j.1600-0609.2010.01510.x
- By:
- Publication type:
- Article
ETS-related gene ERG expression in AML patients is significantly associated with NPM1 mutation status.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Severe congenital neutropenia and pegfilgrastim.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Stem cell transplantation in poor-risk chronic lymphocytic leukemia: assessment of post-transplant minimal residual disease using four- and six-color flow cytometry and allele-specific RQ-PCR.
- Published in:
- European Journal of Haematology, 2008, v. 81, n. 2, p. 100, doi. 10.1111/j.1600-0609.2008.01082.x
- By:
- Publication type:
- Article
Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia.
- Published in:
- European Journal of Haematology, 2008, v. 80, n. 3, p. 201, doi. 10.1111/j.1600-0609.2007.01009.x
- By:
- Publication type:
- Article
Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group.
- Published in:
- European Journal of Haematology, 2007, v. 78, n. 6, p. 477, doi. 10.1111/j.1600-0609.2007.00846.x
- By:
- Publication type:
- Article
Feasibility of fludarabine added to VAD during induction therapy in multiple myeloma: a randomised phase II-study.
- Published in:
- European Journal of Haematology, 2003, v. 70, n. 6, p. 379, doi. 10.1034/j.1600-0609.2003.00068.x
- By:
- Publication type:
- Article
Residual disease detected by flow cytometry is an independent predictor of survival in childhood acute myeloid leukaemia; results of the NOPHO- AML 2004 study.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 4, p. 600, doi. 10.1111/bjh.14093
- By:
- Publication type:
- Article
Absence of polysialylated NCAM is an unfavorable prognostic phenotype for advanced stage neuroblastoma.
- Published in:
- BMC Cancer, 2009, v. 9, p. 1, doi. 10.1186/1471-2407-9-57
- By:
- Publication type:
- Article
Renal impairment compromises the use of total homocysteine and methylmalonic acid but not total vitamin B<sub>12</sub> and holotranscobalamin in screening for vitamin B<sub>12</sub> deficiency in the aged.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2007, v. 45, n. 2, p. 197, doi. 10.1515/CCLM.2007.028
- By:
- Publication type:
- Article
No bias between the first and the new version of radioimmunoassay for serum holo-transcobalamin by Axis-Shield.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Serum oncostatin M in multiple myeloma: association with prognostic factors.
- Published in:
- British Journal of Haematology, 1997, v. 96, n. 1, p. 158, doi. 10.1046/j.1365-2141.1997.8522478.x
- By:
- Publication type:
- Article
GM-CSF RAISES SERUM LEVELS OF β<sub>2</sub>-MICROGLOBULIN AND THYMIDINE KINASE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA.
- Published in:
- British Journal of Haematology, 1996, v. 94, n. 1, p. 129, doi. 10.1046/j.1365-2141.1996.6172066.x
- By:
- Publication type:
- Article
Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma.
- Published in:
- British Journal of Haematology, 1996, v. 92, n. 2, p. 370, doi. 10.1046/j.1365-2141.1996.d01-1470.x
- By:
- Publication type:
- Article
Serum immunoreactive interleukin-6 and C-reactive protein levels in patients with multiple myeloma at diagnosis.
- Published in:
- British Journal of Haematology, 1994, v. 86, n. 2, p. 391, doi. 10.1111/j.1365-2141.1994.tb04748.x
- By:
- Publication type:
- Article
Alpha interferon raises serum beta-2-microglobulin in patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 1991, v. 77, n. 3, p. 335, doi. 10.1111/j.1365-2141.1991.tb08580.x
- By:
- Publication type:
- Article
Single-dose pegfilgrastim is comparable to daily filgrastim in mobilizing peripheral blood stem cells: a case-matched study in patients with lymphoproliferative malignancies.
- Published in:
- Annals of Hematology, 2009, v. 88, n. 7, p. 673, doi. 10.1007/s00277-008-0675-5
- By:
- Publication type:
- Article
Feasibility of prolonged use of interferon-α in metastatic kidney carcinoma.
- Published in:
- Cancer (0008543X), 2001, v. 92, n. 4, p. 761, doi. 10.1002/1097-0142(20010815)92:4<761::AID-CNCR1380>3.0.CO;2-#
- By:
- Publication type:
- Article